GBM1, GBM2 and GBM3, which display a mesenchymal phenotype, were additionally positive for CD44, whereas GBM4 and GBM5 expressed CD133, as expected for non-mesenchymal GBM cells (Supplementary Figure S1). Here, CD44 is linked to glioblastoma.